Army to Announce It Has Developed a Single Vaccine That They Say Protects From All Variants of COVID and SARS

After nearly two years, scientists at the Walter Reed Army Institute of Research believe they have developed a vaccine that is effective against all COVID and SARS variants.

Researchers at the Maryland-based facility expect to officially announce the completion of the vaccine in the coming weeks, Defense One first reported.

News of the new super-vaccine comes as the latest COVID variant, Omicron, drives a fresh explosion in cases across the US, just weeks after it was first spotted in a California COVID patient on December 1. It now accounts for 73 per cent of all diagnoses across the country, with the figure as high as 90 per cent in states including New York and New Jersey.

On Monday night, the United States confirmed its first Omicron death, a man in his 50s from Houston who was unvaccinated and had previously recovered from COVID before being infected again and dying.

The Army began working on the Spike Ferritin Nanoparticle COVID-19 vaccine (SpFN) in early 2020, with a final release date likely to emerge whenever the Army submits its trial results to the Food and Drug Administration. It also remains unclear whether SpFN will be a single or multiple-shot vaccine.

From the beginning, they worked to create a vaccine that would protect against all existing and potential variants of the viruses.

Click here to read more.
Source: Daily Mail